{"id":"selective-serotonin-reuptake-inhibitors","safety":{"commonSideEffects":[{"rate":"25-40","effect":"Sexual dysfunction"},{"rate":"15-25","effect":"Nausea"},{"rate":"10-20","effect":"Headache"},{"rate":"10-15","effect":"Insomnia"},{"rate":"5-15","effect":"Somnolence"},{"rate":"8-15","effect":"Diarrhea"},{"rate":"5-10","effect":"Tremor"},{"rate":"5-10","effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL809","moleculeType":"Small molecule","molecularWeight":"306.24"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By inhibiting the serotonin transporter (SERT), SSRIs prevent the reabsorption of serotonin from the synapse back into the presynaptic neuron. This increases serotonin availability at postsynaptic receptors, enhancing serotonergic neurotransmission. This mechanism is thought to underlie their therapeutic effects in depression, anxiety disorders, and obsessive-compulsive disorder.","oneSentence":"SSRIs block the reuptake of serotonin at the presynaptic neuron, increasing serotonin concentration in the synaptic cleft.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:17.856Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"},{"name":"Obsessive-compulsive disorder"},{"name":"Panic disorder"},{"name":"Social anxiety disorder"},{"name":"Post-traumatic stress disorder"}]},"trialDetails":[{"nctId":"NCT06532604","phase":"NA","title":"Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Centre Psychothérapique de Nancy","startDate":"2026-09-01","conditions":"Major Depressive Disorder","enrollment":108},{"nctId":"NCT07390981","phase":"NA","title":"Intradermal Acupuncture for Assisting SSRI Dose Reduction in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2026-03-01","conditions":"Major Depressive Disorder","enrollment":114},{"nctId":"NCT04497168","phase":"PHASE2","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-04-01","conditions":"Parkinson Disease","enrollment":58},{"nctId":"NCT06559306","phase":"PHASE3","title":"Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-07-25","conditions":"Depressive Disorder, Major","enrollment":752},{"nctId":"NCT05841030","phase":"","title":"A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-28","conditions":"Depressive Disorder, Major","enrollment":545},{"nctId":"NCT07452341","phase":"NA","title":"Effect of Virtual Reality on Depression in Adolescent Females","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-08-01","conditions":"Depression","enrollment":48},{"nctId":"NCT07458022","phase":"PHASE2","title":"MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Child Health Sciences and Children's Hospital, Lahore","startDate":"2025-12-01","conditions":"Major Depressive Diorder","enrollment":50},{"nctId":"NCT07139834","phase":"PHASE1","title":"Pattern Separation in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jeffrey Miller","startDate":"2026-04","conditions":"Major Depressive Disorder (MDD)","enrollment":30},{"nctId":"NCT07359482","phase":"PHASE3","title":"sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2026-03-01","conditions":"Post-COVID, POST-Covid 19, Post-COVID Conditions","enrollment":160},{"nctId":"NCT06049797","phase":"","title":"A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats","status":"ACTIVE_NOT_RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2023-11-15","conditions":"Hot Flashes","enrollment":999},{"nctId":"NCT05550532","phase":"PHASE3","title":"A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-12-06","conditions":"Depressive Disorder, Major, Anhedonia","enrollment":444},{"nctId":"NCT04183205","phase":"PHASE4","title":"Predicting SSRI Efficacy in Veterans With PTSD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-09-11","conditions":"Posttraumatic Stress Disorder, Major Depressive Disorder","enrollment":26},{"nctId":"NCT07399795","phase":"","title":"Citalopram and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":"Chronic Kidney Disease (CKD), Elderly, Outpatient","enrollment":7110},{"nctId":"NCT07387120","phase":"","title":"Sertraline and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01","conditions":"Chronic Kidney Disease (CKD), Elderly, Outpatient","enrollment":6893},{"nctId":"NCT06805851","phase":"","title":"Impact of Depression on Thermoregulation","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-03-01","conditions":"Depression, Selective Serotonin Reuptake Inhibitor","enrollment":64},{"nctId":"NCT07274241","phase":"","title":"Escitalopram and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":"Chronic Kidney Disease (CKD), Elderly, Outpatient","enrollment":12145},{"nctId":"NCT05528224","phase":"NA","title":"Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial","status":"TERMINATED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":46},{"nctId":"NCT06633016","phase":"PHASE2","title":"Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)","status":"RECRUITING","sponsor":"Autobahn Therapeutics, Inc.","startDate":"2024-09-20","conditions":"Major Depressive Disorder","enrollment":230},{"nctId":"NCT07318181","phase":"NA","title":"Building Ukraine's Strength in PTSD Treatment and Research","status":"RECRUITING","sponsor":"University of Luxembourg","startDate":"2026-01-01","conditions":"Post Traumatic Stress Disorder, Post Traumatic Stress Disorder PTSD, Post-Traumatic Stress Disorder, PTSD","enrollment":120},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT03466346","phase":"NA","title":"SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-08-31","conditions":"Depression, Unipolar, Posttraumatic Stress Disorder, Trauma","enrollment":2162},{"nctId":"NCT07239011","phase":"PHASE1, PHASE2","title":"Dapagliflozin in Depression","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-01","conditions":"Depression","enrollment":60},{"nctId":"NCT05455684","phase":"PHASE3","title":"A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-06-22","conditions":"Depressive Disorder, Major, Anhedonia","enrollment":513},{"nctId":"NCT05944926","phase":"PHASE3","title":"Improving Outcomes in Depression in Primary Care in a Low Resource Setting","status":"RECRUITING","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2024-03-18","conditions":"Depression, Depressive Disorder","enrollment":1500},{"nctId":"NCT02773082","phase":"NA","title":"DBS for Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Northwell Health","startDate":"2024-07-06","conditions":"Obsessive-Compulsive Disorder (OCD)","enrollment":50},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":"Type 1 Diabetes Mellitus","enrollment":60},{"nctId":"NCT03513185","phase":"","title":"Assessment of SSD in Outpatients Using SSS-CN","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2017-09-01","conditions":"Somatization Disorder","enrollment":1863},{"nctId":"NCT07192367","phase":"PHASE4","title":"Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder","status":"RECRUITING","sponsor":"Emine Kanmaz","startDate":"2024-11-15","conditions":"Social Anxiety Disorder","enrollment":56},{"nctId":"NCT00285935","phase":"NA","title":"Cellular Aging and Neurobiology of Depression Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-12-16","conditions":"Major Depressive Disorder","enrollment":228},{"nctId":"NCT04829318","phase":"PHASE4","title":"A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment","status":"COMPLETED","sponsor":"Janssen-Cilag Ltd.","startDate":"2021-04-26","conditions":"Depressive Disorder, Major","enrollment":183},{"nctId":"NCT07171814","phase":"","title":"Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework","status":"NOT_YET_RECRUITING","sponsor":"Lianxin Wang","startDate":"2025-09-30","conditions":"Premenstrual Syndrome","enrollment":266},{"nctId":"NCT06443242","phase":"NA","title":"Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Mohammad Farris Iman Leong Bin Abdullah","startDate":"2025-12-01","conditions":"Major Depressive Disorder, Insomnia","enrollment":120},{"nctId":"NCT07161492","phase":"NA","title":"A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2025-09","conditions":"Depressive Disorder, Major, Cognitive Impairment","enrollment":182},{"nctId":"NCT06763081","phase":"","title":"Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2025-03-01","conditions":"Behavioral Activation, Major Depressive Disorder, Anxiety Disorders","enrollment":160},{"nctId":"NCT07153406","phase":"PHASE3","title":"Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2025-09-15","conditions":"Depressive Disorder","enrollment":220},{"nctId":"NCT07144943","phase":"","title":"\"Evolution of Sexual Symptoms in Paraphilic Sexual Offenders With/Without Antiandrogen or SSRI Treatment\"","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2025-09-15","conditions":"Sexual Disorder, Physiological","enrollment":200},{"nctId":"NCT06001021","phase":"NA","title":"Cognitive Behavioral Couple Therapy for Perinatal Distress","status":"COMPLETED","sponsor":"Sameera Shafiq","startDate":"2023-08-15","conditions":"Perinatal Depression, Perinatal Anxiety","enrollment":96},{"nctId":"NCT07110831","phase":"PHASE4","title":"Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria","status":"NOT_YET_RECRUITING","sponsor":"University of Ibadan","startDate":"2025-08-14","conditions":"Depression, HIV","enrollment":168},{"nctId":"NCT06942494","phase":"NA","title":"Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-04-30","conditions":"Obsessive - Compulsive Disorder","enrollment":88},{"nctId":"NCT05976347","phase":"PHASE4","title":"Identifying and Treating Depression in the Orthopaedic Trauma Population","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-06-25","conditions":"Depression","enrollment":100},{"nctId":"NCT07074652","phase":"NA","title":"The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry","status":"COMPLETED","sponsor":"UCLH/UCL Joint Research Office","startDate":"2017-12-01","conditions":"Anxiety","enrollment":145},{"nctId":"NCT07067970","phase":"NA","title":"Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Medipol University","startDate":"2025-10-01","conditions":"Premature Ejaculation","enrollment":250},{"nctId":"NCT06081348","phase":"PHASE2","title":"Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders","status":"RECRUITING","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2024-09-16","conditions":"Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder","enrollment":130},{"nctId":"NCT07062666","phase":"","title":"A Multicentre Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Zhongda Hospital","startDate":"2025-07-30","conditions":"the Objective Diagnosis of Depression","enrollment":2250},{"nctId":"NCT04410341","phase":"PHASE1, PHASE2","title":"The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2020-05-01","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT05830279","phase":"","title":"Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-05-01","conditions":"Nausea With Vomiting Chemotherapy-Induced, Depression, Reactive, Cancer Pain","enrollment":600},{"nctId":"NCT07057011","phase":"NA","title":"Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy","status":"NOT_YET_RECRUITING","sponsor":"South Valley University","startDate":"2025-07-01","conditions":"Premature Ejaculation","enrollment":60},{"nctId":"NCT06955845","phase":"NA","title":"Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asad Ullah Jan","startDate":"2025-05-06","conditions":"PTSD, PTSD - Post Traumatic Stress Disorder","enrollment":60},{"nctId":"NCT06957210","phase":"NA","title":"Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asad Ullah Jan","startDate":"2025-05-06","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":130},{"nctId":"NCT06957223","phase":"NA","title":"Efficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asad Ullah Jan","startDate":"2025-05-06","conditions":"Major Depressive Disorder (MDD)","enrollment":80},{"nctId":"NCT03222570","phase":"PHASE2","title":"An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2018-02-26","conditions":"Depressive Disorder","enrollment":90},{"nctId":"NCT06704594","phase":"PHASE4","title":"Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-05-14","conditions":"Premenstrual Dysphoric Disorder (PMDD)","enrollment":288},{"nctId":"NCT05470465","phase":"PHASE1","title":"Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2022-09-01","conditions":"Hypercapnia, Ventilatory Depression","enrollment":27},{"nctId":"NCT05965401","phase":"NA","title":"Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2023-10-25","conditions":"Depression in Adolescence","enrollment":11},{"nctId":"NCT04973930","phase":"PHASE3","title":"Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2022-03-01","conditions":"Major Depressive Disorder, Breast Cancer, Venlafaxine","enrollment":20},{"nctId":"NCT04597190","phase":"PHASE4","title":"Sequenced Treatment Effectiveness for Posttraumatic Stress","status":"COMPLETED","sponsor":"University of Washington","startDate":"2020-06-01","conditions":"PTSD","enrollment":700},{"nctId":"NCT06328140","phase":"","title":"Sleep Quality, Cognitive Performance, and Computerized Cognitive Training","status":"WITHDRAWN","sponsor":"George West Mental Health Foundation d/b/a Skyland Trail","startDate":"2024-04-15","conditions":"Bipolar Disorder, Major Depressive Disorder, Psychosis","enrollment":""},{"nctId":"NCT04338321","phase":"PHASE3","title":"A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2020-08-21","conditions":"Depressive Disorder, Major","enrollment":676},{"nctId":"NCT03321526","phase":"PHASE2","title":"A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-12-12","conditions":"Depressive Disorder, Major","enrollment":107},{"nctId":"NCT04951609","phase":"PHASE1","title":"A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-02","conditions":"Depressive Disorder, Major","enrollment":31},{"nctId":"NCT05109195","phase":"","title":"A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-10-26","conditions":"Depressive Disorder, Major","enrollment":7},{"nctId":"NCT06853587","phase":"NA","title":"Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2025-02-11","conditions":"Anxiety and Depression","enrollment":452},{"nctId":"NCT04747340","phase":"NA","title":"Clinical Effectiveness of TARA Compared to Standard Treatment for Adolescents and Young Adults With Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Umeå University","startDate":"2021-03-12","conditions":"Depression in Adolescence, Depressive Disorder, Dysthymia and Chronic Depression","enrollment":136},{"nctId":"NCT06231745","phase":"PHASE3","title":"Paroxetine Safety and Efficacy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-31","conditions":"Rheumatoid Arthritis","enrollment":100},{"nctId":"NCT05518149","phase":"PHASE3","title":"A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-09-22","conditions":"Depressive Disorder, Major","enrollment":840},{"nctId":"NCT05458479","phase":"PHASE4","title":"Fluoxetine Treatment of Depression in Down Syndrome","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2022-12-05","conditions":"Down Syndrome, Depression","enrollment":4},{"nctId":"NCT03920410","phase":"NA","title":"Effect of Serotonergic Stimulation on the Gut-brain Axis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Örebro University, Sweden","startDate":"2019-04-24","conditions":"Healthy, Irritable Bowel Syndrome","enrollment":58},{"nctId":"NCT05641623","phase":"PHASE2","title":"OSU6162 as add-on in SSRI/SNRI-resistant Depression","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2022-04-21","conditions":"Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder","enrollment":180},{"nctId":"NCT06860958","phase":"PHASE3","title":"Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-03-01","conditions":"Depressive Disorder, Major","enrollment":60},{"nctId":"NCT06874738","phase":"","title":"A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills","status":"NOT_YET_RECRUITING","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2025-03-08","conditions":"Menopausal Syndrome","enrollment":1000},{"nctId":"NCT05932407","phase":"","title":"A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression","status":"COMPLETED","sponsor":"Takeda","startDate":"2024-06-01","conditions":"Major Depressive Disorder","enrollment":147777},{"nctId":"NCT01778686","phase":"NA","title":"Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors","status":"COMPLETED","sponsor":"Gitte Moos Knudsen","startDate":"2013-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT04637620","phase":"PHASE2","title":"NMDA Modulation in Major Depressive Disorder","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2017-06-01","conditions":"Major Depressive Disorder","enrollment":90},{"nctId":"NCT04598230","phase":"PHASE3","title":"Partners in Caring for Anxious Youth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2021-02-09","conditions":"Anxiety, Separation, Anxiety, Generalized, Anxiety, Social","enrollment":468},{"nctId":"NCT06778824","phase":"NA","title":"Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.","status":"RECRUITING","sponsor":"Hualien Tzu Chi General Hospital","startDate":"2024-04-02","conditions":"Gut-Brain Disorders, GERD Without Erosive Esophagitis","enrollment":610},{"nctId":"NCT06775054","phase":"NA","title":"Cognitive Flexibility in Depression and TMS Response","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2023-03-15","conditions":"Depression - Major Depressive Disorder, Cognitive Flexibility, Treatment Response","enrollment":49},{"nctId":"NCT05792540","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-06-06","conditions":"Depressive Disorder","enrollment":75},{"nctId":"NCT02431845","phase":"NA","title":"Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Severance Hospital","startDate":"2013-01-01","conditions":"Obsessive-Compulsive Disorder","enrollment":200},{"nctId":"NCT05431374","phase":"NA","title":"Measurement-Based Care Vs. Standard Care for Major Depressive Disorder","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2022-09-01","conditions":"Major Depressive Disorder","enrollment":150},{"nctId":"NCT04221997","phase":"PHASE4","title":"Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2019-11-01","conditions":"Anxiety Disorders","enrollment":150},{"nctId":"NCT06644833","phase":"PHASE4","title":"Effective of Transcranial Magnetic Stimulation (TMS) vs Treatment as Usual for First-Episode Depression in Adults","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2025-01-01","conditions":"Major Depressive Disorder","enrollment":120},{"nctId":"NCT05616559","phase":"","title":"Precision Medicine in the Depression Treatment","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-06-15","conditions":"Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction","enrollment":800},{"nctId":"NCT03288675","phase":"NA","title":"Stepped Care AiTBS 2 Depression Study (Ghent)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2017-10-05","conditions":"Depressive Disorder, Major, Treatment Resistant Depression, Melancholia","enrollment":68},{"nctId":"NCT04977232","phase":"NA","title":"Adjunctive Game Intervention for Anhedonia in MDD Patients","status":"COMPLETED","sponsor":"Central South University","startDate":"2021-09-09","conditions":"Depression","enrollment":50},{"nctId":"NCT06545474","phase":"NA","title":"Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2024-09-15","conditions":"Major Depressive Disorder","enrollment":106},{"nctId":"NCT05588102","phase":"NA","title":"Electronic Training of Elderly Depression With Cognitive Impairment","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-05-18","conditions":"Geriatric Depression, Cognitive Impairment","enrollment":128},{"nctId":"NCT02134808","phase":"PHASE4","title":"Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder","status":"COMPLETED","sponsor":"Perry Renshaw","startDate":"2014-11-21","conditions":"Major Depressive Disorder","enrollment":71},{"nctId":"NCT06457581","phase":"NA","title":"Effectiveness of Dry Needling Adjuvant to Selective Serotonin Reputake Inhibitors vs TP Injection for Pain Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2023-11-01","conditions":"Pain, Fibromyalgia","enrollment":35},{"nctId":"NCT06451406","phase":"NA","title":"Hyaluronic Acid Injection in the Glans Penis Versus Selective Serotonin Reuptake Inhibitors for Lifelong Premature","status":"COMPLETED","sponsor":"New Valley University","startDate":"2022-10-01","conditions":"Selective Serotonin Reuptake Inhibitor, Hyaluronic Acid, Glans Penis","enrollment":60},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT04478526","phase":"NA","title":"Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions","status":"COMPLETED","sponsor":"Dr. Nazanin Alavi","startDate":"2020-04-29","conditions":"Generalized Anxiety Disorder","enrollment":115},{"nctId":"NCT06358014","phase":"NA","title":"Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen","status":"RECRUITING","sponsor":"Xiao Wang","startDate":"2023-05-12","conditions":"Postmenopausal Depression, Estrogen","enrollment":40},{"nctId":"NCT06153004","phase":"PHASE3","title":"OptimizeD Pilot Study","status":"COMPLETED","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2023-08-01","conditions":"Depression, Depressive Disorder","enrollment":76},{"nctId":"NCT00553917","phase":"","title":"Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes","status":"TERMINATED","sponsor":"Indiana University","startDate":"2007-11","conditions":"Depression","enrollment":18},{"nctId":"NCT06337539","phase":"","title":"Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants","status":"NOT_YET_RECRUITING","sponsor":"Germans Trias i Pujol Hospital","startDate":"2024-04-01","conditions":"Depression, Inflammation, Antidepressants","enrollment":50},{"nctId":"NCT03993535","phase":"PHASE4","title":"Predicting Treatment Response in Patients With OCD","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2018-10-10","conditions":"Obsessive-Compulsive Disorder","enrollment":250},{"nctId":"NCT02042573","phase":"PHASE4","title":"Preliminary Study to Investigate the Effect of rTMS and SSRI Antidepressants on Leukocyte Expression of the C-FOS and DUSP1 Genes in Patients Treated for Depression","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2013-11-25","conditions":"Depression","enrollment":10},{"nctId":"NCT05720637","phase":"NA","title":"The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder","status":"COMPLETED","sponsor":"Xiaomei Shao","startDate":"2022-11-01","conditions":"Major Depressive Disorder","enrollment":120},{"nctId":"NCT05555940","phase":"NA","title":"Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-10-01","conditions":"Depression","enrollment":80},{"nctId":"NCT03383861","phase":"","title":"Nutrition Status, BMD, and SSRIs","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2005-01","conditions":"BMD","enrollment":13027}],"_emaApprovals":[],"_faersSignals":[{"count":10,"reaction":"DRUG INTERACTION"},{"count":9,"reaction":"TOXICITY TO VARIOUS AGENTS"},{"count":8,"reaction":"ANXIETY"},{"count":6,"reaction":"DRUG INEFFECTIVE"},{"count":5,"reaction":"CONVULSION"},{"count":5,"reaction":"DRUG ABUSE"},{"count":5,"reaction":"SEROTONIN SYNDROME"},{"count":4,"reaction":"DEPRESSION"},{"count":4,"reaction":"LOSS OF CONSCIOUSNESS"},{"count":4,"reaction":"MALAISE"}],"_approvalHistory":[],"publicationCount":10691,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Psychotherapy and TMS","Lexapro®"],"phase":"marketed","status":"active","brandName":"Selective serotonin reuptake inhibitors","genericName":"Selective serotonin reuptake inhibitors","companyName":"Faculdade de Medicina do ABC","companyId":"faculdade-de-medicina-do-abc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SSRIs block the reuptake of serotonin at the presynaptic neuron, increasing serotonin concentration in the synaptic cleft. Used for Major depressive disorder, Generalized anxiety disorder, Obsessive-compulsive disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}